GB0510143D0 — Novel compounds A1
Assigned to Addex Pharmaceuticals SA · Expires 2005-06-22 · 21y expired
What this patent protects
The present invention relates to new tetrazole compounds of formula I wherein B, P, Q, W, R<SUB>1 </SUB>and R<SUB>2 </SUB>are defined in the description: invention compounds are useful for the treatment or prevention of central nervous system disorders as …
USPTO Abstract
The present invention relates to new tetrazole compounds of formula I wherein B, P, Q, W, R<SUB>1 </SUB>and R<SUB>2 </SUB>are defined in the description: invention compounds are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.